Generate Biomedicines, Inc. (GENB)
14.34
+0.35
(+2.50%)
USD |
NASDAQ |
Oct 09, 16:00
14.34
0.00 (0.00%)
After-Hours: 20:00
Generate Biomedicines Total Assets (Quarterly) : 561.69M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 561.69M |
| Date | Value |
|---|---|
| March 31, 2026 | 625.74M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Twist Bioscience Corp. | 672.44M |
| Intellia Therapeutics, Inc. | 857.16M |
| Prime Medicine, Inc. | 249.04M |
| Moderna, Inc. | 10.96B |
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 105.64M |
| Shareholders Equity (Quarterly) | 456.04M |
| Debt to Equity Ratio | 0.1373 |
| Current Ratio | 8.303 |
| Net Debt Paydown Yield | -0.47% |